|
1
|
Assessing the performance of prediction models: a framework for traditional and novel measures.
|
Epidemiology
|
2010
|
14.07
|
|
2
|
Variations in morbidity after radical prostatectomy.
|
N Engl J Med
|
2002
|
7.26
|
|
3
|
Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer.
|
J Clin Oncol
|
2003
|
6.93
|
|
4
|
The surgical learning curve for prostate cancer control after radical prostatectomy.
|
J Natl Cancer Inst
|
2007
|
6.12
|
|
5
|
Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.
|
J Urol
|
2007
|
5.24
|
|
6
|
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.
|
J Clin Oncol
|
2007
|
5.23
|
|
7
|
A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy.
|
Ann Surg Oncol
|
2003
|
5.20
|
|
8
|
Variations in lung cancer risk among smokers.
|
J Natl Cancer Inst
|
2003
|
5.00
|
|
9
|
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
|
J Clin Oncol
|
2005
|
4.89
|
|
10
|
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.
|
J Natl Cancer Inst
|
2007
|
4.64
|
|
11
|
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.
|
J Natl Cancer Inst
|
2006
|
4.14
|
|
12
|
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.
|
JAMA
|
2004
|
4.10
|
|
13
|
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.
|
J Clin Oncol
|
2006
|
4.05
|
|
14
|
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique.
|
Eur Urol
|
2008
|
3.93
|
|
15
|
Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration.
|
J Clin Oncol
|
2002
|
3.93
|
|
16
|
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.
|
J Clin Oncol
|
2009
|
3.74
|
|
17
|
Against diagnosis.
|
Ann Intern Med
|
2008
|
3.69
|
|
18
|
Cancer control with radical prostatectomy alone in 1,000 consecutive patients.
|
J Urol
|
2002
|
3.61
|
|
19
|
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
|
J Clin Oncol
|
2006
|
3.46
|
|
20
|
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
|
Eur Urol
|
2013
|
3.41
|
|
21
|
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
|
J Urol
|
2011
|
3.36
|
|
22
|
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.
|
J Urol
|
2003
|
3.27
|
|
23
|
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.
|
J Urol
|
2009
|
3.24
|
|
24
|
Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
|
Ann Surg
|
2006
|
3.23
|
|
25
|
Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters.
|
J Urol
|
2005
|
2.98
|
|
26
|
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
|
Clin Cancer Res
|
2010
|
2.87
|
|
27
|
Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas.
|
Ann Surg
|
2004
|
2.84
|
|
28
|
An updated catalog of prostate cancer predictive tools.
|
Cancer
|
2008
|
2.82
|
|
29
|
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy.
|
Cancer
|
2005
|
2.78
|
|
30
|
Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
|
Radiology
|
2005
|
2.71
|
|
31
|
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
|
J Urol
|
2005
|
2.69
|
|
32
|
Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.
|
BJU Int
|
2010
|
2.59
|
|
33
|
Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.
|
J Urol
|
2008
|
2.57
|
|
34
|
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
|
J Urol
|
2008
|
2.57
|
|
35
|
The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy.
|
Cancer
|
2004
|
2.54
|
|
36
|
International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy.
|
J Clin Oncol
|
2002
|
2.51
|
|
37
|
Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
|
Radiology
|
2005
|
2.49
|
|
38
|
The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.
|
Eur Urol
|
2008
|
2.39
|
|
39
|
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma.
|
J Urol
|
2005
|
2.30
|
|
40
|
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy.
|
J Urol
|
2006
|
2.30
|
|
41
|
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
|
J Urol
|
2012
|
2.24
|
|
42
|
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).
|
J Urol
|
2004
|
2.23
|
|
43
|
Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.
|
J Clin Oncol
|
2011
|
2.21
|
|
44
|
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.
|
Cancer
|
2009
|
2.18
|
|
45
|
Meta-analysis: Its strengths and limitations.
|
Cleve Clin J Med
|
2008
|
2.15
|
|
46
|
Assessing individual risk for prostate cancer.
|
J Clin Oncol
|
2007
|
2.13
|
|
47
|
Judging new markers by their ability to improve predictive accuracy.
|
J Natl Cancer Inst
|
2003
|
2.11
|
|
48
|
Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone.
|
Urology
|
2013
|
2.04
|
|
49
|
Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group.
|
J Clin Oncol
|
2004
|
2.04
|
|
50
|
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
|
Radiother Oncol
|
2004
|
2.01
|
|
51
|
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.
|
Clin Cancer Res
|
2008
|
1.96
|
|
52
|
A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
|
J Urol
|
2003
|
1.96
|
|
53
|
Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.
|
J Urol
|
2008
|
1.95
|
|
54
|
Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
|
Ann Surg Oncol
|
2004
|
1.95
|
|
55
|
Comparisons of nomograms and urologists' predictions in prostate cancer.
|
Semin Urol Oncol
|
2002
|
1.88
|
|
56
|
High expression of the Met receptor in prostate cancer metastasis to bone.
|
Urology
|
2002
|
1.83
|
|
57
|
A nomogram that predicts the presence of sentinel node metastasis in melanoma with better discrimination than the American Joint Committee on Cancer staging system.
|
Ann Surg Oncol
|
2005
|
1.83
|
|
58
|
Predicting 6-year mortality risk in patients with type 2 diabetes.
|
Diabetes Care
|
2008
|
1.81
|
|
59
|
Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
|
J Urol
|
2009
|
1.81
|
|
60
|
An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.
|
Ann Intern Med
|
2007
|
1.80
|
|
61
|
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
|
Eur Urol
|
2006
|
1.76
|
|
62
|
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
|
J Urol
|
2007
|
1.75
|
|
63
|
Initial biopsy outcome prediction--head-to-head comparison of a logistic regression-based nomogram versus artificial neural network.
|
Eur Urol
|
2006
|
1.73
|
|
64
|
Prostate cancer nomograms: an update.
|
Eur Urol
|
2006
|
1.71
|
|
65
|
The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis.
|
BJU Int
|
2007
|
1.71
|
|
66
|
Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.
|
Cancer
|
2008
|
1.70
|
|
67
|
The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
|
Acta Diabetol
|
2009
|
1.69
|
|
68
|
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.69
|
|
69
|
Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.
|
Urology
|
2005
|
1.63
|
|
70
|
Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation.
|
J Clin Oncol
|
2007
|
1.63
|
|
71
|
Individualized prediction of colon cancer recurrence using a nomogram.
|
J Clin Oncol
|
2008
|
1.61
|
|
72
|
Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group.
|
Eur Urol
|
2007
|
1.60
|
|
73
|
Preoperative nomogram predicting 12-year probability of metastatic renal cancer.
|
J Urol
|
2008
|
1.60
|
|
74
|
Method for evaluating prediction models that apply the results of randomized trials to individual patients.
|
Trials
|
2007
|
1.58
|
|
75
|
Critical review of prostate cancer predictive tools.
|
Future Oncol
|
2009
|
1.57
|
|
76
|
A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
|
J Urol
|
2007
|
1.57
|
|
77
|
Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.
|
J Urol
|
2004
|
1.55
|
|
78
|
The association of community health indicators with outcomes for kidney transplant recipients in the United States.
|
Arch Surg
|
2012
|
1.53
|
|
79
|
Systematic review of statistical methods used in molecular marker studies in cancer.
|
Cancer
|
2008
|
1.53
|
|
80
|
Predicting quality of life after radical prostatectomy: results from CaPSURE.
|
J Urol
|
2004
|
1.52
|
|
81
|
A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery.
|
Obstet Gynecol
|
2014
|
1.52
|
|
82
|
Nomograms to predict isolated loco-regional or distant recurrence among women with uterine cancer.
|
Gynecol Oncol
|
2012
|
1.48
|
|
83
|
Nomogram to predict seminal vesicle invasion using the status of cancer at the base of the prostate on systematic biopsy.
|
Int J Urol
|
2010
|
1.47
|
|
84
|
Does mechanical bowel preparation ameliorate damage from rectal injury in radical prostatectomy? Analysis of 151 rectal injury cases.
|
Int J Urol
|
2013
|
1.47
|
|
85
|
Achieving optimal outcomes after radical prostatectomy.
|
J Clin Oncol
|
2005
|
1.46
|
|
86
|
Assessing the incremental value of diagnostic and prognostic markers: a review and illustration.
|
Eur J Clin Invest
|
2011
|
1.46
|
|
87
|
Comparative analysis of three risk assessment tools in Australian patients with prostate cancer.
|
BJU Int
|
2011
|
1.46
|
|
88
|
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
|
J Urol
|
2005
|
1.45
|
|
89
|
Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression.
|
Clin Cancer Res
|
2004
|
1.45
|
|
90
|
Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations.
|
Pharmacoeconomics
|
2010
|
1.45
|
|
91
|
Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system.
|
Cancer
|
2005
|
1.45
|
|
92
|
Performance comparisons in major uro-oncological surgeries between the USA and Japan.
|
Int J Urol
|
2014
|
1.44
|
|
93
|
Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
|
J Urol
|
2008
|
1.44
|
|
94
|
Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping.
|
J Urol
|
2004
|
1.43
|
|
95
|
Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example.
|
Med Decis Making
|
2004
|
1.43
|
|
96
|
Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens.
|
Int J Urol
|
2010
|
1.43
|
|
97
|
Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.
|
J Urol
|
2005
|
1.42
|
|
98
|
Validation of the postoperative nomogram for 12-year sarcoma-specific mortality.
|
Cancer
|
2004
|
1.42
|
|
99
|
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
|
World J Urol
|
2011
|
1.42
|
|
100
|
Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma.
|
Int J Urol
|
2014
|
1.42
|
|
101
|
Predicting life expectancy in men with clinically localized prostate cancer.
|
J Urol
|
2006
|
1.42
|
|
102
|
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate?
|
Transplantation
|
2004
|
1.41
|
|
103
|
Comparative 5-year outcomes of brachytherapy and surgery for prostate cancer.
|
Brachytherapy
|
2011
|
1.40
|
|
104
|
Urinary continence after radical retropubic prostatectomy: relationship with membranous urethral length on preoperative endorectal magnetic resonance imaging.
|
J Urol
|
2002
|
1.39
|
|
105
|
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
|
Urology
|
2010
|
1.38
|
|
106
|
Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
|
J Clin Oncol
|
2005
|
1.37
|
|
107
|
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
|
BJU Int
|
2008
|
1.35
|
|
108
|
Improved prediction of prostate cancer recurrence through systems pathology.
|
J Clin Invest
|
2007
|
1.35
|
|
109
|
Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets.
|
J Clin Oncol
|
2013
|
1.35
|
|
110
|
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy.
|
J Clin Oncol
|
2005
|
1.35
|
|
111
|
Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex.
|
J Urol
|
2006
|
1.34
|
|
112
|
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.
|
Crit Rev Oncol Hematol
|
2010
|
1.34
|
|
113
|
Validation of a nomogram for predicting disease-specific survival after an R0 resection for gastric carcinoma.
|
Cancer
|
2005
|
1.34
|
|
114
|
Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
|
Radiology
|
2003
|
1.33
|
|
115
|
A nomogram for individualized estimation of survival among patients with brain metastasis.
|
Neuro Oncol
|
2012
|
1.32
|
|
116
|
Predicting survival after curative colectomy for cancer: individualizing colon cancer staging.
|
J Clin Oncol
|
2011
|
1.32
|
|
117
|
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
|
J Clin Oncol
|
2005
|
1.31
|
|
118
|
Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.
|
Radiology
|
2004
|
1.30
|
|
119
|
Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature.
|
Eur Urol
|
2010
|
1.30
|
|
120
|
Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer.
|
J Clin Oncol
|
2002
|
1.28
|
|
121
|
Testosterone as a predictor of pathological stage in clinically localized prostate cancer.
|
J Urol
|
2005
|
1.28
|
|
122
|
Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer.
|
BJU Int
|
2011
|
1.26
|
|
123
|
Nomograms to predict patency after microsurgical vasectomy reversal.
|
J Urol
|
2011
|
1.26
|
|
124
|
Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.
|
Radiology
|
2006
|
1.24
|
|
125
|
Benchmarking lung cancer mortality rates in current and former smokers.
|
Chest
|
2004
|
1.23
|
|
126
|
Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes.
|
Br J Haematol
|
2007
|
1.22
|
|
127
|
Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis.
|
J Clin Oncol
|
2002
|
1.21
|
|
128
|
Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.
|
Radiology
|
2004
|
1.21
|
|
129
|
Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading.
|
BJU Int
|
2007
|
1.21
|
|
130
|
Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram.
|
Ann Surg Oncol
|
2005
|
1.20
|
|
131
|
Inventory of prostate cancer predictive tools.
|
Curr Opin Urol
|
2008
|
1.20
|
|
132
|
Radical prostatectomy nomograms in black American men: accuracy and applicability.
|
J Urol
|
2003
|
1.19
|
|
133
|
A nomogram to predict the probability of passing the American Board of Internal Medicine examination.
|
Med Educ Online
|
2012
|
1.19
|
|
134
|
Validation of a nomogram for predicting positive repeat biopsy for prostate cancer.
|
J Urol
|
2005
|
1.17
|
|
135
|
A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma.
|
J Am Coll Surg
|
2007
|
1.16
|
|
136
|
Validating a prognostic model.
|
Cancer
|
2006
|
1.15
|
|
137
|
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.
|
J Urol
|
2004
|
1.14
|
|
138
|
Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapy.
|
J Clin Oncol
|
2007
|
1.14
|
|
139
|
Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.
|
J Urol
|
2008
|
1.13
|
|
140
|
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.11
|
|
141
|
Is year of radical prostatectomy a predictor of outcome in prostate cancer?
|
J Urol
|
2004
|
1.11
|
|
142
|
Nomograms as predictive models.
|
Semin Urol Oncol
|
2002
|
1.11
|
|
143
|
Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
|
J Urol
|
2002
|
1.11
|
|
144
|
Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring.
|
Stat Med
|
2012
|
1.09
|
|
145
|
A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results.
|
J Urol
|
2003
|
1.09
|
|
146
|
A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.
|
BJU Int
|
2009
|
1.09
|
|
147
|
Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate.
|
J Urol
|
2006
|
1.09
|
|
148
|
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
|
Int J Cancer
|
2007
|
1.09
|
|
149
|
Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
|
Ann Surg Oncol
|
2012
|
1.09
|
|
150
|
Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer.
|
Urology
|
2003
|
1.08
|
|
151
|
A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer.
|
BJU Int
|
2007
|
1.08
|
|
152
|
A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session.
|
J Urol
|
2003
|
1.08
|
|
153
|
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
|
Diabetes Care
|
2010
|
1.08
|
|
154
|
Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
|
Cancer Res
|
2003
|
1.07
|
|
155
|
Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.
|
Ann Surg
|
2006
|
1.07
|
|
156
|
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
|
Gynecol Oncol
|
2007
|
1.07
|
|
157
|
Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy.
|
Cancer
|
2005
|
1.06
|
|
158
|
p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.
|
BJU Int
|
2009
|
1.06
|
|
159
|
Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer.
|
J Urol
|
2004
|
1.06
|
|
160
|
Racial and ethnic differences in preference-based health status measure.
|
Curr Med Res Opin
|
2006
|
1.06
|
|
161
|
Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.
|
Cancer
|
2009
|
1.05
|
|
162
|
Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
|
J Urol
|
2004
|
1.05
|
|
163
|
Prognostic models and algorithms in renal cell carcinoma.
|
Urol Clin North Am
|
2008
|
1.05
|
|
164
|
Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials.
|
Cancer
|
2013
|
1.05
|
|
165
|
Development of nomogram to predict acute urinary retention or surgical intervention, with or without dutasteride therapy, in men with benign prostatic hyperplasia.
|
Urology
|
2006
|
1.04
|
|
166
|
A measure of health-related quality of life among patients with localized prostate cancer: results from ongoing scale development.
|
Clin Prostate Cancer
|
2005
|
1.04
|
|
167
|
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.
|
Urology
|
2007
|
1.04
|
|
168
|
The 'CaP Calculator': an online decision support tool for clinically localized prostate cancer.
|
BJU Int
|
2010
|
1.04
|
|
169
|
Nomogram use for the prediction of indolent prostate cancer: impact on screen-detected populations.
|
Cancer
|
2007
|
1.04
|
|
170
|
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
|
Gynecol Oncol
|
2011
|
1.04
|
|
171
|
Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
|
BJU Int
|
2011
|
1.03
|
|
172
|
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.
|
Cancer Res
|
2003
|
1.02
|
|
173
|
Nomograms for prostate cancer.
|
BJU Int
|
2006
|
1.02
|
|
174
|
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.
|
Am Heart J
|
2008
|
1.01
|
|
175
|
Utilities should not be multiplied: evidence from the preference-based scores in the United States.
|
Med Care
|
2008
|
1.00
|
|
176
|
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.
|
World J Urol
|
2011
|
1.00
|
|
177
|
Partial nephrectomy for renal cortical tumors: pathologic findings and impact on outcome.
|
Urology
|
2002
|
1.00
|
|
178
|
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
|
J Sex Med
|
2008
|
0.99
|
|
179
|
New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.
|
Cancer Biol Ther
|
2011
|
0.98
|
|
180
|
Long-term follow-up of bilateral sporadic renal tumors.
|
Urology
|
2003
|
0.98
|
|
181
|
The impact of tumour location on the histological subtype of renal cortical tumours.
|
BJU Int
|
2006
|
0.98
|
|
182
|
How to judge a tumor marker.
|
Nat Clin Pract Oncol
|
2005
|
0.97
|
|
183
|
Improving the decision to pursue a phase 3 clinical trial by adjusting for patient-specific factors in evaluating phase 2 treatment efficacy data.
|
Med Decis Making
|
2007
|
0.97
|
|
184
|
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.
|
Urol Oncol
|
2002
|
0.96
|
|
185
|
Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer.
|
Rev Urol
|
2004
|
0.95
|
|
186
|
Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.
|
Ann Surg Oncol
|
2012
|
0.95
|
|
187
|
The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer.
|
Front Oncol
|
2012
|
0.95
|
|
188
|
Development and validation of a 32-gene prognostic index for prostate cancer progression.
|
Proc Natl Acad Sci U S A
|
2013
|
0.95
|
|
189
|
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
|
World J Urol
|
2012
|
0.94
|
|
190
|
The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.94
|
|
191
|
Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening.
|
Urology
|
2003
|
0.94
|
|
192
|
Importance of implant dosimetry for patients undergoing prostate brachytherapy.
|
Urology
|
2003
|
0.93
|
|
193
|
Cross-cultural validation of the UCLA prostate cancer index.
|
Urology
|
2003
|
0.93
|
|
194
|
Preoperative anemia and perioperative outcomes in patients who undergo elective spine surgery.
|
Spine (Phila Pa 1976)
|
2013
|
0.93
|
|
195
|
Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
|
BJU Int
|
2009
|
0.93
|
|
196
|
Multicenter Comparison of Machine Learning Methods and Conventional Regression for Predicting Clinical Deterioration on the Wards.
|
Crit Care Med
|
2016
|
0.93
|
|
197
|
Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
|
Urology
|
2011
|
0.92
|
|
198
|
Evaluation of neoadjuvant therapy and histopathologic response in primary, high-grade retroperitoneal sarcomas using the sarcoma nomogram.
|
Cancer
|
2010
|
0.92
|
|
199
|
How to tell if a new marker improves prediction.
|
Eur Urol
|
2011
|
0.91
|
|
200
|
A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
|
Cancer
|
2007
|
0.91
|
|
201
|
Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men.
|
Eur Urol
|
2004
|
0.91
|
|
202
|
Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
|
AJR Am J Roentgenol
|
2006
|
0.91
|
|
203
|
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma.
|
Cancer
|
2003
|
0.91
|
|
204
|
Recent advances in evaluating the prognostic value of a marker.
|
Scand J Clin Lab Invest Suppl
|
2010
|
0.91
|
|
205
|
Predicting outcomes in renal cell carcinoma.
|
Curr Opin Urol
|
2005
|
0.91
|
|
206
|
Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.
|
J Urol
|
2004
|
0.90
|
|
207
|
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
|
Prostate
|
2005
|
0.90
|
|
208
|
Postoperative nomogram predicting the 9-year probability of prostate cancer recurrence after permanent prostate brachytherapy using radiation dose as a prognostic variable.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.90
|
|
209
|
Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT).
|
Urol Oncol
|
2003
|
0.89
|
|
210
|
A predictive nomogram for recurrence of carcinoma of the major salivary glands.
|
JAMA Otolaryngol Head Neck Surg
|
2013
|
0.89
|
|
211
|
Active surveillance for low-risk prostate cancer.
|
Crit Rev Oncol Hematol
|
2012
|
0.89
|
|
212
|
Nomograms. Introduction.
|
Semin Urol Oncol
|
2002
|
0.89
|
|
213
|
Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia.
|
Arch Otolaryngol Head Neck Surg
|
2011
|
0.89
|
|
214
|
Sarcoma nomogram: validation and a model to evaluate impact of therapy.
|
J Am Coll Surg
|
2007
|
0.88
|
|
215
|
Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients.
|
Urology
|
2007
|
0.88
|
|
216
|
Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
|
Cancer Res
|
2002
|
0.88
|
|
217
|
Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
|
J Urol
|
2010
|
0.88
|
|
218
|
Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis.
|
J Urol
|
2006
|
0.88
|
|
219
|
Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma.
|
Cancer
|
2013
|
0.88
|
|
220
|
Herpes simplex virus based gene therapy enhances the efficacy of mitomycin C for the treatment of human bladder transitional cell carcinoma.
|
J Urol
|
2005
|
0.88
|
|
221
|
Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling.
|
BJU Int
|
2010
|
0.87
|
|
222
|
Paper standard gamble: a paper-based measure of standard gamble utility for current health.
|
Int J Technol Assess Health Care
|
2003
|
0.87
|
|
223
|
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
|
Int J Cancer
|
2006
|
0.87
|
|
224
|
Seizure freedom score: a new simple method to predict success of epilepsy surgery.
|
Epilepsia
|
2014
|
0.87
|
|
225
|
Validation of postoperative nomograms in prostate cancer patients with long-term follow-up.
|
Urology
|
2011
|
0.87
|
|
226
|
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.87
|
|
227
|
Prediction tools in surgical oncology.
|
Surg Oncol Clin N Am
|
2012
|
0.87
|
|
228
|
Validating a predictive model for presence of additional disease in the non-sentinel lymph nodes of a woman with sentinel node positive breast cancer.
|
Ann Surg Oncol
|
2007
|
0.86
|
|
229
|
The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer.
|
Urology
|
2008
|
0.86
|
|
230
|
Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma.
|
Head Neck
|
2008
|
0.86
|
|
231
|
Colorectal cancer predicted risk online (CRC-PRO) calculator using data from the multi-ethnic cohort study.
|
J Am Board Fam Med
|
2014
|
0.86
|
|
232
|
An improved prognostic model for stage T1a and T1b prostate cancer by assessments of cancer extent.
|
Mod Pathol
|
2010
|
0.86
|
|
233
|
Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands.
|
Ann Surg Oncol
|
2013
|
0.86
|
|
234
|
Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?
|
Urology
|
2005
|
0.86
|
|
235
|
Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets.
|
Eur Urol
|
2010
|
0.86
|
|
236
|
Predicting patient discharge disposition after total joint arthroplasty in the United States.
|
J Arthroplasty
|
2009
|
0.86
|
|
237
|
Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
|
Cancer
|
2011
|
0.86
|
|
238
|
Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.
|
BJU Int
|
2006
|
0.86
|
|
239
|
Doc, what are my chances? A conversation about prognostic uncertainty.
|
Eur Urol
|
2010
|
0.86
|
|
240
|
Long-term benefits of elective radiotherapy after prostatectomy for patients with positive surgical margins.
|
J Urol
|
2006
|
0.85
|
|
241
|
Use of nomograms for personalized decision-analytic recommendations.
|
Med Decis Making
|
2009
|
0.85
|
|
242
|
Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?
|
J Urol
|
2003
|
0.85
|
|
243
|
Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
|
Urology
|
2007
|
0.85
|
|
244
|
Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis.
|
J Clin Oncol
|
2009
|
0.84
|
|
245
|
Formalized prediction of clinically significant prostate cancer: is it possible?
|
Asian J Androl
|
2012
|
0.84
|
|
246
|
Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
|
Urol Oncol
|
2003
|
0.84
|
|
247
|
Using the landmark method for creating prediction models in large datasets derived from electronic health records.
|
Health Care Manag Sci
|
2014
|
0.83
|
|
248
|
Nomogram for predicting malignancy in thyroid nodules using clinical, biochemical, ultrasonographic, and cytologic features.
|
Surgery
|
2010
|
0.83
|
|
249
|
Predicting clinical end points: treatment nomograms in prostate cancer.
|
Semin Oncol
|
2003
|
0.83
|
|
250
|
Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.
|
BJU Int
|
2009
|
0.83
|
|
251
|
Nomogram to preoperatively predict the probability of requiring epididymovasostomy during vasectomy reversal.
|
J Urol
|
2011
|
0.83
|
|
252
|
Ketorolac: safe and effective analgesia for the management of renal cortical tumors with partial nephrectomy.
|
J Urol
|
2004
|
0.83
|
|
253
|
Gene based prediction of clinically localized prostate cancer progression after radical prostatectomy.
|
J Urol
|
2010
|
0.83
|
|
254
|
Editorial comment on: development, validation, and head-to-head comparison of logistic regression-based nomograms and artificial neural network models predicting prostate cancer on initial extended biopsy.
|
Eur Urol
|
2008
|
0.82
|
|
255
|
Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
|
Prostate
|
2002
|
0.82
|
|
256
|
Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy.
|
J Urol
|
2002
|
0.82
|
|
257
|
Risk grouping versus risk continuum in patients with clinically localized prostate cancer: a taxometric test.
|
J Urol
|
2010
|
0.82
|
|
258
|
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
|
J Urol
|
2005
|
0.82
|
|
259
|
Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases.
|
HPB (Oxford)
|
2009
|
0.82
|
|
260
|
Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific rt-PCR assay for human glandular kallikrein.
|
J Clin Oncol
|
2003
|
0.82
|
|
261
|
Primer: using decision analysis to improve clinical decision making in urology.
|
Nat Clin Pract Urol
|
2006
|
0.82
|
|
262
|
Evaluation of preoperative therapy for pancreatic cancer using a prognostic nomogram.
|
Ann Surg Oncol
|
2006
|
0.82
|
|
263
|
Factors affecting choice between ureterostomy, ileal conduit and continent reservoir after radical cystectomy: Japanese series.
|
Int J Clin Oncol
|
2014
|
0.81
|
|
264
|
Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes.
|
Am J Cardiovasc Dis
|
2013
|
0.81
|
|
265
|
An empirical approach to model selection through validation for censored survival data.
|
J Biomed Inform
|
2011
|
0.81
|
|
266
|
The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.
|
Rev Urol
|
2004
|
0.81
|
|
267
|
A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
|
Cancer
|
2002
|
0.81
|
|
268
|
Hidden selection bias deriving from donor organ characteristics does not affect performance evaluations of kidney transplant centers.
|
Med Care
|
2010
|
0.80
|
|
269
|
Screening for Lynch syndrome in the general population-letter.
|
Cancer Prev Res (Phila)
|
2011
|
0.80
|
|
270
|
Validation of two preoperative Kattan nomograms predicting recurrence after radical prostatectomy for localized prostate cancer in Turkey: a multicenter study of the Uro-oncology Society.
|
Urology
|
2009
|
0.80
|
|
271
|
Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer.
|
Pathology
|
2010
|
0.80
|
|
272
|
Nomograms are difficult to beat.
|
Eur Urol
|
2007
|
0.80
|
|
273
|
Measurements of cancer extent in a conservatively treated prostate cancer biopsy cohort.
|
Virchows Arch
|
2010
|
0.80
|
|
274
|
Effect of smoking on the perioperative outcomes of patients who undergo elective spine surgery.
|
Spine (Phila Pa 1976)
|
2013
|
0.79
|
|
275
|
Are nomograms needed in the management of bladder cancer?
|
Urol Oncol
|
2010
|
0.79
|
|
276
|
A simulation model of colorectal cancer surveillance and recurrence.
|
BMC Med Inform Decis Mak
|
2014
|
0.79
|
|
277
|
Markers and meaning of primary treatment failure.
|
Urol Clin North Am
|
2003
|
0.78
|
|
278
|
Does mechanical bowel preparation improve quality of laparoscopic nephrectomy? Propensity score-matched analysis in Japanese series.
|
Urology
|
2013
|
0.78
|
|
279
|
Predicting Risk of Urinary Incontinence and Adverse Events After Midurethral Sling Surgery in Women.
|
Obstet Gynecol
|
2016
|
0.78
|
|
280
|
Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer.
|
World J Urol
|
2013
|
0.78
|
|
281
|
Prediction of morbidity and mortality in patients with type 2 diabetes.
|
PeerJ
|
2013
|
0.78
|
|
282
|
Unmet needs in the prediction and detection of metastases in prostate cancer.
|
Oncologist
|
2013
|
0.78
|
|
283
|
Tailored cancer outcome prediction and informed consent.
|
Semin Oncol
|
2010
|
0.78
|
|
284
|
Predicting the discharge status after liver transplantation at a single center: a new approach for a new era.
|
Liver Transpl
|
2012
|
0.77
|
|
285
|
Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.
|
BJU Int
|
2005
|
0.77
|
|
286
|
Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience.
|
Int J Cancer
|
2010
|
0.77
|
|
287
|
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
288
|
Impact of unilateral interposition sural nerve grafting on recovery of urinary function after radical prostatectomy.
|
Urology
|
2004
|
0.77
|
|
289
|
Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012-2013.
|
Cancer Sci
|
2014
|
0.77
|
|
290
|
Nomogram for selecting thyroid nodules for ultrasound-guided fine-needle aspiration biopsy based on a quantification of risk of malignancy.
|
Head Neck
|
2012
|
0.77
|
|
291
|
High-dose rate brachytherapy compared with open radical prostatectomy for the treatment of high-risk prostate cancer: 10 year biochemical freedom from relapse.
|
BJU Int
|
2012
|
0.77
|
|
292
|
Prediction models for postpartum urinary and fecal incontinence in primiparous women.
|
Female Pelvic Med Reconstr Surg
|
2013
|
0.76
|
|
293
|
Pilot study of a utilities-based treatment decision intervention for prostate cancer patients.
|
Clin Prostate Cancer
|
2002
|
0.76
|
|
294
|
Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram.
|
J Crohns Colitis
|
2011
|
0.76
|
|
295
|
Modeling potential time to event data with competing risks.
|
Lifetime Data Anal
|
2013
|
0.75
|
|
296
|
Adding propensity scores to pure prediction models fails to improve predictive performance.
|
PeerJ
|
2013
|
0.75
|
|
297
|
Stages of prediction model comparison.
|
Eur Urol
|
2012
|
0.75
|
|
298
|
The ultimate prostate cancer biopsy decision support tool.
|
Eur Urol
|
2009
|
0.75
|
|
299
|
PSA velocity and prostate cancer.
|
N Engl J Med
|
2004
|
0.75
|
|
300
|
Sural Nerve Interposition Grafting during Radical Prostatectomy.
|
Rev Urol
|
2002
|
0.75
|
|
301
|
Predictive factors in prostate cancer: implications for decision making.
|
Cancer Invest
|
2003
|
0.75
|
|
302
|
Prostate cancer: does genetic score justify early prostate biopsy?
|
Nat Rev Urol
|
2013
|
0.75
|
|
303
|
Making and evaluating a statistical prediction model for the absolute risk of prostate cancer recurrence.
|
Cancer
|
2011
|
0.75
|
|
304
|
Prediction models for transitional cell carcinoma.
|
J Urol
|
2009
|
0.75
|
|
305
|
Editorial comment.
|
Urology
|
2010
|
0.75
|
|
306
|
Comparing prediction tools.
|
Eur Urol
|
2010
|
0.75
|
|
307
|
Editorial comment.
|
Urology
|
2009
|
0.75
|
|
308
|
Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
|
Rev Urol
|
2004
|
0.75
|
|
309
|
Classification and regression trees versus nomograms: a bone scan positivity example.
|
Eur Urol
|
2010
|
0.75
|
|
310
|
Validation and comparison of the two Kattan nomograms in patients with prostate cancer treated with (125) iodine brachytherapy.
|
BJU Int
|
2011
|
0.75
|
|
311
|
Prostate cancer postoperative nomogram scores and obesity.
|
PLoS One
|
2011
|
0.75
|
|
312
|
Editorial comment.
|
J Urol
|
2012
|
0.75
|
|
313
|
Predicting prostate cancer behavior--what is a urologist to do?
|
J Urol
|
2008
|
0.75
|
|
314
|
Calibration plots for risk prediction models in the presence of competing risks.
|
Stat Med
|
2014
|
0.75
|
|
315
|
The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
|
Brachytherapy
|
2003
|
0.75
|
|
316
|
Nomograms are more meaningful than severity-adjusted institutional comparisons for reporting outcomes.
|
Eur Urol
|
2006
|
0.75
|
|
317
|
External radiotherapy and permanent prostate brachytherapy in patients with localized prostate cancer.
|
Brachytherapy
|
2002
|
0.75
|
|
318
|
Nomogram to predict successful placement in surgical subspecialty fellowships using applicant characteristics.
|
J Surg Educ
|
2012
|
0.75
|
|
319
|
The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
|
Cancer
|
2009
|
0.75
|
|
320
|
A chronological database to support outcomes research in prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.75
|
|
321
|
What patients newly diagnosed with clinically localized prostate cancer need to see: an editorial dialogue.
|
Eur Urol
|
2010
|
0.75
|
|
322
|
Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy.
|
J Urol
|
2012
|
0.75
|
|
323
|
Predictive modeling in prostate cancer: a conference summary.
|
Eur Urol
|
2008
|
0.75
|
|
324
|
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.
|
Jpn J Clin Oncol
|
2013
|
0.75
|
|
325
|
A hybrid approach to survival model building using integration of clinical and molecular information in censored data.
|
IEEE/ACM Trans Comput Biol Bioinform
|
2012
|
0.75
|
|
326
|
Impact of the COVID-19 pandemic on healthcare workers risk of infection and outcomes in a large, integrated health system.
|
Res Sq
|
2020
|
0.75
|
|
327
|
Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
|
J Clin Oncol
|
2002
|
0.75
|
|
328
|
A power series beta Weibull regression model for predicting breast carcinoma.
|
Stat Med
|
2015
|
0.75
|
|
329
|
Using prostate-specific antigen screening and nomograms to assess risk and predict outcomes in the management of prostate cancer.
|
BJU Int
|
2006
|
0.75
|